Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib for COVID-19-related pneumonia
2020-001185-11Phase 2Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Aug 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of baricitinib in coronavirus disease 2019 (COVID-19) and pneumonia, sponsored by IRCCS San Matteo Foundation. Started Aug 2020; status: terminated.
02
Drugs
baricitinib
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on 2020-001185-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001185-11.